References

Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

Adams LE, Hess EV (1991) Drug-related lupus. Drug Safety 6:431-449

Alarcon-Segovia D, Fishbein E, Reyes PA, Dies H, Shwadsky S (1972) Antinuclear antibodies in patients on anticonvulsant therapy. Clin Exp Immunol 12:39-47 Alloway JA, Salata MP (1995) Quinidine-induced rheumatic syndromes. Semin Arthritis Rheum 24:315-322

Amrhein JA, Kenny FM, Ross D (1970) Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J Pediatr 76:54-63 Aucoin DP, Peterson ME, Hurvitz AI, Drayer DE, Lahita RG, Quimby FW, Reidenberg M M (1985) Propylthiouracil-induced immune-mediated disease in the cat. J Pharmacol Exp Ther 234:13-18

Aucoin DP, Rubin RL, Peterson ME, Reidenberg MM, Drayer DE, Hurvitz AI, Lahita RG (1988) Dose-dependent induction of anti-native DNA antibodies in cats bypropylthiouracil.Arthri-tis Rheum 31:688-692

Batchelor JR, Welsh KI, Tinoco RM, Dollery CT, Hughes GR, Bernstein R, Ryan P, Naish PF, Aber GM, Bing RF, Russel GI (1980) Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet 1:1107-1109 Beernink DH, Miller JJ (1973) Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children. J Pediatr 82:113-117 Blomgren SE, Condemi JJ,Vaughn JH (1972) Procainamide-induced lupus erythematosus: clinical and laboratory observations. Am J Med 52:338-348

Booth RJ,Wilson JD, Bullock JY (1982) ß-Adrenergic-receptor blockers and antinuclear antibodies in hypertension. Clin Pharmacol Ther 31:555-558 Brand C, Davidson A, Littlejohn G, Ryan P (1984) Hydralazine-induced lupus: no association with HLA-DR4. Lancet 1:462 Burlingame RW, Rubin RL (1991) Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest 88:680-690 Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low dose therapy. Br Med J 289:410-412 Canoso R, Lewis M, Yunis E (1982) Association of HLA-Bw44 with chlorpromazine-induced autoantibodies. Clin Immunol Immunopathol 25:278-282 CAST (1989) Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 406-412

Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN (2000) Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 43:2383-2390 Chin G, Kong N, Lee B, Rose I (1991) Penicillamine induced lupus-like syndrome in a patient with classical rheumatoid arthritis. J Rheumatol 18:947-948 Christie DJ, Mullen PC,Aster RH (1985) Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 75:310-314 Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B (1988) Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 140:2197-2200

Derksen R, Kater L (1985) Lupus anticoagulant: revival of an old phenomenon. Clin Exp Rheumatol 3:349-357

Donker AJ, Venuto RC, Vladutiu AO, Brentjens JR, Andres GA (1984) Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Clin Immunol Immunopath 30:142-155 Dubois EL, Wallace DJ (1987) Drugs that exacerbate and induce systemic lupus erythematosus In: Wallace DJ, Dubois EL (eds) Dubois' Lupus Erythematosus. Lea & Febiger, Philadelphia, pp 450-469

Dubois EL, Tallman E, Wonka RA (1972) Chlorpromazine-induced systemic lupus erythematosus: case report and review of the literature. J Am Med Assoc 221:595-596 Dubroff LM, Reid R Jr, Papalian M (1981) Molecular models for hydralazine-related systemic lupus erythematosus. Arthritis Rheum 24:1082-1085 Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ (2000) Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 142:461-467

Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115-4119

Fritzler MJ, Tan EM (1978) Antibodies to histones in drug-induced and idiopathic lupus erythe-

matosus. J Clin Invest 62:560-567 Fukuyama S, Kajiwara E, Suzuki N, Miyazaki N, Sadoshima S, Onoyama K (2000) Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature. Am J Gastroenterol 95:310-312 Ghate J, Turner M, Rudek M, Figg W, Dahut W, Dyer V, Pluda J, Reed E (2001) Drug-induced lupus associated with COL-3: report of 3 cases. Arch Dermatol 137:471-474 Gleichmann E, Pals WT, Rolink AG, Radaszkiewicz T, Gleichmann H (1984) Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol Today 5:324-332

Gleichmann H (1982) Systemic lupus erythematosus triggered by diphenylhydantoin. Arthritis Rheum 25:1387-1388

Graninger WB, Hassfeld W, Pesau BB, Machold KP, Zielinski CC, Smolen JS (1991) Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Rheumatol 18:1621-1622 Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E (1998) Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19:133-141 Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B (1997) Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br J Rheumatol 36: 1089-1094

Hahn BH, Sharp GC, Irvin WS, Kantor OS, Gardner CA, Bagby MK, Perry HM Jr, Osterland CK (1972) Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus. Ann Intern Med 76:365-374 Harkcom TM, Conn DL, Holley KE (1978) D-Penicillamine and lupus erythematosus-like syndrome. Ann Intern Med 89:1012 Henningsen NC, Cederberg A, Hanson A, Johansson BW (1975) Effects of long-term treatment with procaine amide. Acta Med Scand 198:475-482 Hieronymus T, Grotsch P, Blank N, Grunke M, Capraru D, Geiler T, Winkler S, Kalden JR, Lorenz HM (2000) Chlorpromazine induces apoptosis in activated human lymphoblasts: a mechanism supporting the induction of drug-induced lupus erythematosus? Arthritis Rheum 43:1994-2004

Hoffman BJ (1945) Sensitivity to sulfadiazine resembling acute lupus erythematosus. Arch Dermatol Syph 51:190-192

Hofstra A, Uetrecht JP (1993) Metabolism of hydralazine to a reactive intermediate by the oxidizing system of activated leukocytes. Chem Biol Interact 89:183-196 Jaffe IA (1981) Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases. Springer Semin Immunopathol 4:193-207 Jain KK (1991) Systemic lupus erythematosus (SLE)-like syndromes associated with carba-

mazepine therapy. Drug Saf 6:350-360 Ju C, Uetrecht JP (1999) Detection of 2-hydroxyiminostilbene in the urine of patients taking car-bamazepine and its oxidation to a reactive iminoquinone intermediate. J Pharmacol Exp Ther 288:51-56

Kalyanaraman B, Sohnle PG (1985) Generation of free radical intermediates from foreign compounds by neutrophil-derived oxidants. J Clin Invest 75:1618-1622 Kammuller ME, Bloksma N, Seinen W (1988) Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds. J Toxicol Clin Toxicol 26:157-174

Khan MF, Kaphalia BS, Prabhakar BS, Kanz MF, Ansari GA (1995) Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 134:155-160 Kilburn KH, Warshaw RH (1992) Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to tri-chloroethylene and other chemicals in well water. Environ Res 57:1-9 Knezevic W, Mastaglia FL, Quintner J, Zilko PJ (1984) Guillain-Barré syndrome and pemphigus foliaceus associated with D-penicillamine therapy. Aust NZ J Med 14:50-52 Kretz-Rommel A, Duncan SR, Rubin RL (1997) Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus. J Clin Invest 99:18881896

Kretz-Rommel A, Rubin RL (1999) Persistence of autoreactive T cell drive is required to elicit anti- chromatin antibodies in a murine model of drug-induced lupus. J Immunol 162: 813-820

Laversuch CJ, Collins DA, Charles PJ, Bourke BE (1995) Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol 34:435-439 Lawson TM,Amos N, Bulgen D,Williams BD (2001) Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) 40:329-335 Lee SL, Chase PH (1975) Drug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum 5:83-103

Lessard E, Fortin A, Belanger PM, Beaune P, Hamelin BA, Turgeon J (1997) Role of CYP2D6 in the N-hydroxylation of procainamide. Pharmacogenetics 7:381-390 Machold KP, Smolen JS (1990) Interferon-gamma induced exacerbation of systemic lupus erythematosus. J Rheumatol 17:831-832 Mackie BS, Mackie LE (1999) The PABA story. Australas J Dermatol 40:51-53 Maddrey WC, Boitnott JK (1973) Isoniazid hepatitis. Ann Intern Med 79:1-12 Malinow MR, Bardana EJ, Pirofsky B, Craig S, McLaughlin P (1982) Systemic lupus erythemato-sus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 216:415-417

Markham A, Lamb HM (2000) Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs 59:1341-1359 Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T,Kano S (1992) Minocycline-related lupus. Lancet 340:1553

Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A (1990) Autoantibodies against neu-trophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 81:380-383 Perry HM (1973) Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. Am J Med 54:58-72 Perry HM, Tan EM, Cordody S, Sahamato A (1970) Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms on hypertensive patients treated with hydralazine. J Lab Clin Med 76:114-125 Portanova JP, Arndt RE, Tan EM, Kotzin BL (1987) Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions. J Immunol 138:446451

Price EJ,Venables PJ (1995) Drug-induced lupus. Drug Saf 12:283-290

Raftery EB, Denman AM (1973) Systemic lupus erythematosus syndrome induced by practolol. Br Med J 2:452-455

Reidenberg MM (1983) Aromatic amines and the pathogenesis of lupus erythematosus. Am J Med 75:1037-1042

Reidenberg MM, Durant PJ, Harris RA, De Boccardo G, Lahita R, Stenzel KH (1983) Lupus ery-

thematosus-like disease due to hydrazine. Am J Med 75:365-370 Reza MJ, Dornfeld L, Goldberg LS (1975) Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus. Arthritis Rheum 18:335-338 Rich MW (1996) Drug-induced lupus: the list of culprits grows. Postgrad Med 100:299-308 Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M (1990) Evidence for impaired T cell methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33:1665-1673 Ronnblom LE, Alm GV, Oberg KE (1990) Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 227:207-210

Rothfield NF, Bierer WF, Garfield JW (1978) Isoniazid induction of antinuclear antibodies: a prospective study. Ann Intern Med 88:650-652 Rutgeerts P, D'Haens G, Targan S,Vasiliaskas E, Hanauer SB, Present DH, Mayer L,Van Hogezand RA, Braakman T, DeWoody KL, Schaible TF, Van Deventer SJ (1999) Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology 117:761-769 Schaffer JV, Davidson DM, McNiff JM, Bolognia JL (2001) Perinuclear antineutrophilic cytoplas-mic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 44:198-206 Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M (1991) Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68:1536-1537

Shapiro KS, Pinn VW, Harrington JT, Levey AS (1984) Immune complex glomerulnephritis in hydralazine-induced SLE.Am J Kidney Dis 3:270-274

Shapiro LE, Knowles SR, Shear NH (1997) Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 133:1224-1230 Shapiro LE, Uetrecht J, Shear NH (2001) Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: the biochemical basis. J Am Acad Dermatol 45:787-789 Shear NH, Spielberg SP (1988) Anticonvulsant hypersensitivity syndrome. J Clin Invest 82:1826-1832 Sim E, Law SA (1985) Hydralazine binds covalently to complement component C4: different reactivity of C4A and C4B gene products. FEBS 184:323-327 Sim E, Stanley L, Gill EW, Jones A (1988) Metabolites of procainamide andpractolol inhibit complement components C3 and C4. Biochem J 251:323-326 Spielberg SP, Gordon GB, Blake DA, Mellits ED, Bross DS (1981) Anticonvulsant toxicity in vitro:

possible role of arene oxides. J Pharmacol Exp Ther 217:386-389 Stec GP, Lertora JJL, Atkinson AJ, Nevin MJ, Kushner W, Jones C, Schmid FR, Askenazi J (1979) Remission of procainamide-induced lupus erythematosus with N-acetylprocainamide therapy. Ann Intern Med 90:799-801 Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Krieg AM (1991) NIH conference.

Systemic lupus erythematosus. Ann Intern Med 115:548-559 Tournade H, Pelletier L, Pasquier R,Vial M, Mandet C, Druet P (1990) D-Penicillamine-induced autoimmunity in Brown-Norway rats: similarities with HgCl2-Induced autoimmunity. J Immunol 144:2985-2991 Uetrecht JP (1988) Mechanism of drug-induced lupus. Chem Res Toxicol 1:133-143 Uetrecht JP (1996) Drug-induced lupus: possible mechanisms and their implications for prediction of which new drugs may induce lupus. Expert Opinion on Invest Drugs 5:851-860 Uetrecht JP, Woosley RL (1981) Acetylator phenotype and lupus erythematosus. Clin Pharma-cokin 6:118-134

Waldhauser L, Uetrecht J (1991) Oxidation of propylthiouracil to reactive metabolites by activated neutrophils: implications for agranulocytosis. Drug Metab Dispos 19:354-359 Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphopro-liferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317

Wilson JD, Bullock JY, Sutherland DC, Main C, O'Brien KP (1978) Antinuclear antibodies in patients receiving non-practolol beta-blockers. Br Med J 1:14-16 Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA (1978) Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. NEnglJMed 298:1157-1159 Yung RL, Richardson BC (1994) Drug-induced lupus. Rheum Dis Clin North Am 20:61-86 Zarrabi MH, Zucker S, Miller F, Derman RM, Romano GS, Hartnett JA,Varma AO (1979) Imuno-logic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med 91:194-199.

Was this article helpful?

0 0
Osteoarthritis

Osteoarthritis

Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.

Get My Free Ebook


Post a comment